サンプル依頼リスト カート
  • English
  • Korean
表紙：胃腸薬の世界市場（2022年）
市場調査レポート
商品コード
1063057

胃腸薬の世界市場（2022年）

Gastrointestinal Drugs Global Market Report 2022
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 300 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
胃腸薬の世界市場（2022年）
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 300 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の胃腸薬市場について調査し、市場規模や予測、市場力学、セグメント・地域別の市場分析、競合情勢、戦略、主要企業のプロファイル等の情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 レポートの構造

第3章 胃腸薬市場の特徴

  • 市場の定義
  • 主要セグメンテーション

第4章 胃腸薬市場の製品分析

  • 主な製品/サービス
  • 主な機能と差別化要因
  • 開発製品

第5章 胃腸薬市場のサプライチェーン

  • サプライチェーン
  • 流通
  • エンドカスタマー

第6章 胃腸薬市場の顧客情報

  • 顧客の選好
  • 最終用途の市場規模と成長

第7章 胃腸薬市場の動向と戦略

第8章 胃腸薬に対するCOVID-19の影響

第9章 胃腸薬の市場規模と成長

  • 市場規模
  • 市場成長実績（金額）
    • 市場促進要因
    • 市場抑制要因
  • 市場成長予測（金額）
    • 市場促進要因
    • 市場抑制要因

第10章 胃腸薬市場の地域分析

  • 地域別：市場（金額）
  • 地域別：市場実績と予測
  • 地域別：市場成長と市場シェアの比較

第11章 胃腸薬市場のセグメンテーション

  • 市場実績と予測（金額）：タイプ別
  • 医薬品
  • 生物製剤
  • 市場実績と予測（金額）：薬剤タイプ別
  • 制酸剤
  • 抗潰瘍剤
  • 抗肥満
  • 制吐剤
  • 止瀉薬
  • 市場実績と予測（金額）：流通チャネル別
  • 病院薬局
  • 小売薬局/ドラッグストア
  • その他
  • 市場実績と予測（金額）：投与経路別
  • 経口
  • 非経口
  • その他
  • 市場実績と予測（金額）：医薬品分類別
  • ブランド薬
  • ジェネリック薬
  • 市場実績と予測（金額）：購入方法別
  • 処方薬
  • 市販薬

第12章 胃腸薬市場の指標

  • 世界市場規模、GDPの割合
  • 世界市場：一人当たりの平均支出

第13章 アジア太平洋の胃腸薬市場

  • 市場概要
  • 地域情報、COVID-19の影響、市場情報、背景情報、政府のイニシアチブ、規制、規制機関、主要な協会、徴収される税金、法人税の構造、投資、主要企業
  • 国別：市場（金額）
  • 国別：市場実績と予測
  • 国別：市場成長と市場シェアの比較
  • 市場指標
  • タイプ別：市場（金額）
  • 国別：市場分析
    • 中国
    • オーストラリア
    • 香港
    • インド
    • インドネシア
    • 日本
    • マレーシア
    • ニュージーランド
    • フィリピン
    • シンガポール
    • 韓国
    • タイ
    • ベトナム

第14章 西欧の胃腸薬市場

  • 市場概要
  • 国別：市場（金額）
  • 国別：市場実績と予測
  • 国別：市場成長と市場シェアの比較
  • 市場指標
  • タイプ別：市場（金額）
  • 国別：市場分析
    • オーストリア
    • ベルギー
    • デンマーク
    • フィンランド
    • フランス
    • ドイツ
    • アイルランド
    • イタリア
    • オランダ
    • ノルウェー
    • ポルトガル
    • スペイン
    • スウェーデン
    • スイス
    • 英国

第15章 東欧の胃腸薬市場

  • 市場概要
  • 国別：市場（金額）
  • 国別：市場実績と予測
  • 国別：市場成長と市場シェアの比較
  • 市場指標
  • タイプ別：市場（金額）
  • 国別：市場分析
    • チェコ共和国
    • ポーランド
    • ルーマニア
    • ロシア

第16章 北米の胃腸薬市場

  • 市場概要
  • 国別：市場（金額）
  • 国別：市場実績と予測
  • 国別：市場成長と市場シェアの比較
  • 市場指標
  • タイプ別：市場（金額）
  • 国別：市場分析
    • カナダ
    • メキシコ
    • 米国

第17章 南米の胃腸薬市場

  • 市場概要
  • 国別：市場（金額）
  • 国別：市場実績と予測
  • 国別：市場成長と市場シェアの比較
  • 市場指標
  • タイプ別：市場（金額）
  • 国別：市場分析
    • アルゼンチン
    • ブラジル
    • チリ
    • コロンビア
    • ペルー
    • ベネズエラ

第18章 中東の胃腸薬市場

  • 市場概要
  • 国別：市場（金額）
  • 国別：市場実績と予測
  • 国別：市場成長と市場シェアの比較
  • 市場指標
  • タイプ別：市場（金額）
  • 国別：市場分析
    • サウジアラビア
    • イスラエル
    • トルコ
    • アラブ首長国連邦

第19章 アフリカの胃腸薬市場

  • 市場概要
  • 国別：市場（金額）
  • 国別：市場実績と予測
  • 国別：市場成長と市場シェアの比較
  • 市場指標
  • タイプ別：市場（金額）
  • 国別：市場分析
    • エジプト
    • ナイジェリア
    • 南アフリカ

第20章 胃腸薬市場の競合情勢

  • 競争市場概要
  • 市場シェア
  • 企業プロファイル
    • Takeda Pharmaceuticals
    • Bayer AG
    • Abbott Laboratories
    • Otsuka Holdings Co ltd
    • Johnson & Johnson

第21章 胃腸薬市場における主な合併と買収

第22章 市場の背景：医薬品市場

  • 医薬品市場の特徴
  • 世界の医薬品市場の実績と予測、成長：セグメント別（金額）
  • 世界の医薬品市場：地域別（金額）
  • 世界の医薬品市場の実績と予測：地域別
  • 世界の医薬品市場：タイプ別セグメンテーション（金額）

第23章 提言

  • 2026年の世界の胃腸薬市場：成長国
  • 2026年の世界の胃腸薬市場：成長セグメント
  • 2026年の世界の胃腸薬市場：成長戦略

第24章 付録

第25章 著作権と免責事項

目次
Product Code: r685

“Gastrointestinal Drugs Global Market Report 2022” from The Business Research Company covers this critical market and the impact on it from the Covid 19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for gastrointestinal drugs. Vitamins and Minerals play a crucial role in the treatment of pateints with Covid 19 as they are used as immunity boosters.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is experiencing rapid growth due to the coronavirus and how it is likely to stabilize as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the gastrointestinal drugs market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Gastrointestinal Drugs Market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider gastrointestinal drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The gastrointestinal drugs market section of the report gives context. It compares the gastrointestinal drugs market with other segments of the gastrointestinal drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, gastrointestinal drugs indicators comparison.

Scope

Markets Covered:

  • 1) By Type: Pharmaceutical Drugs; Biologics
  • 2) By Drug Type: Antacids; Antiulcerants; Antiobesity; Antiemetics And Antinauseants; Antidiarrhoeals
  • 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
  • 4) By Route Of Administration: Oral; Parenteral; Others
  • 5) By Drug Classification: Branded Drugs; Generic Drugs
  • 6) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs
  • Companies Mentioned: Takeda Pharmaceuticals; Bayer AG; Abbott Laboratories; Otsuka Holdings Co. ltd.; Johnson & Johnson
  • Metrics Covered: Number of Enterprises; Number of Employees
  • Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, gastrointestinal drugs indicators comparison.
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Report Structure

3. Gastrointestinal Drugs Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Gastrointestinal Drugs Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Gastrointestinal Drugs Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Gastrointestinal Drugs Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Gastrointestinal Drugs Market Trends And Strategies

8. Impact Of COVID-19 On Gastrointestinal Drugs

9. Gastrointestinal Drugs Market Size And Growth

  • 9.1. Market Size
  • 9.2. Historic Market Growth, Value ($ Billion)
    • 9.2.1. Drivers Of The Market
    • 9.2.2. Restraints On The Market
  • 9.3. Forecast Market Growth, Value ($ Billion)
    • 9.3.1. Drivers Of The Market
    • 9.3.2. Restraints On The Market

10. Gastrointestinal Drugs Market Regional Analysis

  • 10.1. Global Gastrointestinal Drugs Market, 2021, By Region, Value ($ Billion)
  • 10.2. Global Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • 10.3. Global Gastrointestinal Drugs Market, Growth And Market Share Comparison, By Region

11. Gastrointestinal Drugs Market Segmentation

  • 11.1. Global Gastrointestinal Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Pharmaceutical Drugs
  • Biologics
  • 11.2. Global Gastrointestinal Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Antacids
  • Antiulcerants
  • Antiobesity
  • Antiemetics And Antinauseants
  • Antidiarrhoeals
  • 11.3. Global Gastrointestinal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies/ Drug Stores
  • Others
  • 11.4. Global Gastrointestinal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Oral
  • Parenteral
  • Others
  • 11.5. Global Gastrointestinal Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Branded Drugs
  • Generic Drugs
  • 11.6. Global Gastrointestinal Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Prescription-Based Drugs
  • Over-The-Counter Drugs

12. Gastrointestinal Drugs Market Metrics

  • 12.1. Gastrointestinal Drugs Market Size, Percentage Of GDP, 2016-2026, Global
  • 12.2. Per Capita Average Gastrointestinal Drugs Market Expenditure, 2016-2026, Global

13. Asia-Pacific Gastrointestinal Drugs Market

  • 13.1. Asia-Pacific Gastrointestinal Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 13.2. Asia-Pacific, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • 13.3. Asia-Pacific, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 13.4. Asia-Pacific, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 13.5. Asia-Pacific, Gastrointestinal Drugs Market Metrics
    • 13.5.1. Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, Asia-Pacific Countries
  • 13.6. Asia-Pacific Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 13.7. Asia-Pacific Gastrointestinal Drugs Market: Country Analysis
    • 13.7.1. China Gastrointestinal Drugs Market
      • 13.7.1.1. China Gastrointestinal Drugs Market Overview
      • 13.7.1.2. China Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.1.3. China Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.2. Australia Gastrointestinal Drugs Market
      • 13.7.2.1. Australia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.2.2. Australia Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.3. Hong Kong Gastrointestinal Drugs Market
      • 13.7.3.1. Hong Kong Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.4. India Gastrointestinal Drugs Market
      • 13.7.4.1. India Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.4.2. India Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.5. Indonesia Gastrointestinal Drugs Market
      • 13.7.5.1. Indonesia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.5.2. Indonesia Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.6. Japan Gastrointestinal Drugs Market
      • 13.7.6.1. Japan Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.6.2. Japan Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.7. Malaysia Gastrointestinal Drugs Market
      • 13.7.7.1. Malaysia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.8. New Zealand Gastrointestinal Drugs Market
      • 13.7.8.1. New Zealand Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.9. Philippines Gastrointestinal Drugs Market
      • 13.7.9.1. Philippines Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.10. Singapore Gastrointestinal Drugs Market
      • 13.7.10.1. Singapore Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.11. South Korea Gastrointestinal Drugs Market
      • 13.7.11.1. South Korea Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.11.2. South Korea Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.12. Thailand Gastrointestinal Drugs Market
      • 13.7.12.1. Thailand Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.13. Vietnam Gastrointestinal Drugs Market
      • 13.7.13.1. Vietnam Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14. Western Europe Gastrointestinal Drugs Market

  • 14.1. Western Europe Gastrointestinal Drugs Market Overview
  • 14.2. Western Europe, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • 14.3. Western Europe, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 14.4. Western Europe, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 14.5. Western Europe, Gastrointestinal Drugs Market Metrics
    • 14.5.1. Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, Western Europe Countries
  • 14.6. Western Europe Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 14.7. Western Europe Gastrointestinal Drugs Market: Country Analysis
    • 14.7.1. Austria Gastrointestinal Drugs Market
      • 14.7.1.1. Austria Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.2. Belgium Gastrointestinal Drugs Market
      • 14.7.2.1. Belgium Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.3. Denmark Gastrointestinal Drugs Market
      • 14.7.3.1. Denmark Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.4. Finland Gastrointestinal Drugs Market
      • 14.7.4.1. Finland Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.5. France Gastrointestinal Drugs Market
      • 14.7.5.1. France Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 14.7.5.2. France Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.6. Germany Gastrointestinal Drugs Market
      • 14.7.6.1. Germany Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 14.7.6.2. Germany Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.7. Ireland Gastrointestinal Drugs Market
      • 14.7.7.1. Ireland Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.8. Italy Gastrointestinal Drugs Market
      • 14.7.8.1. Italy Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.9. Netherlands Gastrointestinal Drugs Market
      • 14.7.9.1. Netherlands Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.10. Norway Gastrointestinal Drugs Market
      • 14.7.10.1. Norway Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.11. Portugal Gastrointestinal Drugs Market
      • 14.7.11.1. Portugal Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.12. Spain Gastrointestinal Drugs Market
      • 14.7.12.1. Spain Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.13. Sweden Gastrointestinal Drugs Market
      • 14.7.13.1. Sweden Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.14. Switzerland Gastrointestinal Drugs Market
      • 14.7.14.1. Switzerland Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.15. UK Gastrointestinal Drugs Market
      • 14.7.15.1. UK Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 14.7.15.2. UK Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

15. Eastern Europe Gastrointestinal Drugs Market

  • 15.1. Eastern Europe Gastrointestinal Drugs Market Overview
  • 15.2. Eastern Europe, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • 15.3. Eastern Europe, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 15.4. Eastern Europe, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 15.5. Eastern Europe, Gastrointestinal Drugs Market Metrics
    • 15.5.1. Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, Eastern Europe Countries
  • 15.6. Eastern Europe Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 15.7. Eastern Europe Gastrointestinal Drugs Market: Country Analysis
    • 15.7.1. Czech Republic Gastrointestinal Drugs Market,
      • 15.7.1.1. Czech Republic Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 15.7.2. Poland Gastrointestinal Drugs Market
      • 15.7.2.1. Poland Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 15.7.3. Romania Gastrointestinal Drugs Market
      • 15.7.3.1. Romania Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 15.7.4. Russia Gastrointestinal Drugs Market
      • 15.7.4.1. Russia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 15.7.4.2. Russia Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

16. North America Gastrointestinal Drugs Market

  • 16.1. North America Gastrointestinal Drugs Market Overview
  • 16.2. North America, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • 16.3. North America, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 16.4. North America, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 16.5. North America, Gastrointestinal Drugs Market Metrics
    • 16.5.1. Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, North America Countries
  • 16.6. North America Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 16.7. North America Gastrointestinal Drugs Market: Country Analysis
    • 16.7.1. Canada Gastrointestinal Drugs Market
      • 16.7.1.1. Canada Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 16.7.2. Mexico Gastrointestinal Drugs Market
      • 16.7.2.1. Mexico Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 16.7.3. USA Gastrointestinal Drugs Market
      • 16.7.3.1. USA Gastrointestinal Drugs Market Overview
      • 16.7.3.2. USA Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 16.7.3.3. USA Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

17. South America Gastrointestinal Drugs Market

  • 17.1. South America Gastrointestinal Drugs Market Overview
  • 17.2. South America, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • 17.3. South America, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 17.4. South America, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 17.5. South America, Gastrointestinal Drugs Market Metrics
    • 17.5.1. Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, South America Countries
  • 17.6. South America Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 17.7. South America Gastrointestinal Drugs Market: Country Analysis
    • 17.7.1. Argentina Gastrointestinal Drugs Market
      • 17.7.1.1. Argentina Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 17.7.2. Brazil Gastrointestinal Drugs Market
      • 17.7.1.1. Brazil Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 17.7.2.2. Brazil Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 17.7.3. Chile Gastrointestinal Drugs Market
      • 17.7.3.1. Chile Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 17.7.4. Colombia Gastrointestinal Drugs Market
      • 17.7.4.1. Colombia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 17.7.5. Peru Gastrointestinal Drugs Market
      • 17.7.5.1. Peru Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 17.7.6. Venezuela Gastrointestinal Drugs Market
      • 17.7.6.1. Venezuela Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

18. Middle East Gastrointestinal Drugs Market

  • 18.1. Middle East Gastrointestinal Drugs Market Overview
  • 18.2. Middle East, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • 18.3. Middle East, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 18.4. Middle East, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 18.5. Middle East, Gastrointestinal Drugs Market Metrics
    • 18.5.1. Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, Middle East Countries
  • 18.6. Middle East Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 18.7. Middle East Gastrointestinal Drugs Market: Country Analysis
    • 18.7.1. Saudi Arabia Gastrointestinal Drugs Market
      • 18.7.1.1. Saudi Arabia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 18.7.2. Israel Gastrointestinal Drugs Market
      • 18.7.2.1. Israel Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 18.7.3. Turkey Gastrointestinal Drugs Market
      • 18.7.3.1. Turkey Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 18.7.4. UAE Gastrointestinal Drugs Market
      • 18.7.4.1. UAE Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

19. Africa Gastrointestinal Drugs Market

  • 19.1. Africa Gastrointestinal Drugs Market Overview
  • 19.2. Africa, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • 19.3. Africa, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 19.4. Africa, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 19.5. Africa, Gastrointestinal Drugs Market Metrics
    • 19.5.1. Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, Africa Countries
  • 19.6. Africa Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 19.7. Africa Gastrointestinal Drugs Market: Country Analysis
    • 19.7.1. Egypt Gastrointestinal Drugs Market
      • 19.7.1.1. Egypt Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 19.7.2. Nigeria Gastrointestinal Drugs Market
      • 19.7.2.1. Nigeria Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 19.7.3. South Africa Gastrointestinal Drugs Market
      • 19.7.3.1. South Africa Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

20. Gastrointestinal Drugs Market Competitive Landscape

  • 20.1. Competitive Market Overview
  • 20.2. Market Shares
  • 20.3. Company Profiles
    • 20.3.1. Takeda Pharmaceuticals
      • 20.3.1.1. Company Overview
      • 20.3.1.2. Products And Services
      • 20.3.1.3. Strategy
      • 20.3.1.4. Financial Performance
    • 20.3.2. Bayer AG
      • 20.3.2.1. Company Overview
      • 20.3.2.2. Products And Services
      • 20.3.2.3. Strategy
      • 20.3.2.4. Financial Performance
    • 20.3.3. Abbott Laboratories
      • 20.3.3.1. Company Overview
      • 20.3.3.2. Products And Services
      • 20.3.3.3. Strategy
      • 20.3.3.4. Financial Performance
    • 20.3.4. Otsuka Holdings Co ltd
      • 20.3.4.1. Company Overview
      • 20.3.4.2. Products And Services
      • 20.3.4.3. Strategy
      • 20.3.4.4. Financial Performance
    • 20.3.5. Johnson & Johnson
      • 20.3.5.1. Company Overview
      • 20.3.5.2. Products And Services
      • 20.3.5.3. Strategy
      • 20.3.5.4. Financial Performance

21. Key Mergers And Acquisitions In The Gastrointestinal Drugs Market

22. Market Background: Pharmaceutical Drugs Market

  • 22.1. Pharmaceutical Drugs Market Characteristics
  • 22.2. Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F Growth, By Segment, Value ($ Billion), Global
  • 22.3. Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)
  • 22.4. Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • 22.5. Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)

23. Recommendations

  • 23.1. Global Gastrointestinal Drugs Market In 2026- Growth Countries
  • 23.2. Global Gastrointestinal Drugs Market In 2026- Growth Segments
  • 23.3. Global Gastrointestinal Drugs Market In 2026- Growth Strategies

24. Appendix

  • 24.1. NAICS Definitions Of Industry Covered In This Report
  • 24.2. Abbreviations
  • 24.3. Currencies
  • 24.4. Research Inquiries
  • 24.5. The Business Research Company

25. Copyright And Disclaimer